Endomyocardial biopsy in pediatric heart transplant recipients: A useful exercise? (Analysis of 1169 biopsies)

Pediatric Transplantation

Volumn 4, Issue 3, 2000, Pages 186-192

  Wagner, Kerstin ^a   Oliver, Mark C ^a   Boyle, Gerard J ^a   Miller, Susan A ^a   Law, Yuk M ^a   Pigula, Frank ^a   Webber, Steven A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Endomyocardial biopsy; Immunosuppression; Pediatric heart transplantation

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

AGE; ARTICLE; CHILD; DIAGNOSTIC ACCURACY; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MONITORING; NEWBORN;

ADOLESCENT; AGE FACTORS; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ENDOCARDIUM; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MYOCARDIUM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033928758     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2000.00100.x     Document Type: Article

References (15)

1. BOUCEK MM, MATHIS CM, BOUCEK RJ, et al. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation: comparison with endomyocardial biopsy. J Heart Lung Transplant 1994: 13: 66-73.
2. BALZER DT, MOORHEAD S, SAFFITZ JE, HUDDLESTON CB, SPRAY TL, CANTER CE. Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant 1995: 14: 1095-1101.
3. ZALES VR, CRAWFORD S, BACKER CL, et al. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. J Am Coll Cardiol 1994: 23: 766-771.
4. BRAUNLIN EA, SHUMWAY SJ, BOLMAN RM, et al. Usefulness of surveillance endomyocardial biopsy after pediatric cardiac transplantation. Clin Transplant 1998: 12: 184-189.
5. WEBBER SA. 15 years of pediatric heart transplantation at the University of Pittsburgh: lessons learned and future prospects. Pediatr Transplantation 1997: 1: 8-21.
6. BILLINGHAM ME, CARY NR, HAMMOND EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant 1990: 9: 587-593.
7. SHADDY RE, NAFTEL DC, KIRKLIN JK, et al. Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Circulation 1996: 94: II69-II73.
8. MILLS RM, NAFTEL DC, KIRKLIN JK, et al. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 1997: 16: 813-821.
9. WEBBER SA, NAFTEL DC, PARKER J, et al. Late rejection greater than 1 year after pediatric heart transplantation: an ominous finding. J Heart Lung Transplant 1999: 18: 69.
10. POPHAL SG, SIGFUSSON G, BOOTH KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999: 34: 2105-2110.
11. PAHL E, ZALES VR, FRICKER FJ, ADDONIZIO LJ. Postransplant coronary artery disease in children. A multicenter national survey. Circulation 1994: 90: II56-II60.
12. CHIAVARELLI M, BOUCEK MM, NEHLSEN-CANNARELLA SL, et al. Neonatal cardiac transplantation, intermediate-term results and incidence of rejection. Arch Surg 1992: 127: 1072-1076.
13. NEHLSEN-CANNARELLA SL. The unique newborn immune response. J Heart Lung Transplant 1991: 10: 828-830.
14. CHINNOCK RE. Pediatric heart transplantation at Loma Linda: 1985-1996. In: CECKA JM, TERASAKI P, eds. Clinical Transplants 1996. UCLA Tissue Typing Laboratory, 1996: 145-151.
15. SAWADA S, SUZUKI G, KAWASE Y, TAKAKU F. Novel immunosuppressive agent FK 506. In vitro effects on cloned T cell activation. J Immunol 1987: 139: 1797-1803.